{"id":"apetiviton-bc","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Nausea"},{"rate":"5-10%","effect":"Diarrhea"},{"rate":"5-10%","effect":"Vomiting"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"The exact mechanism of action of Apetiviton BC is not well understood, but it is believed to involve the inhibition of a key enzyme involved in the regulation of blood sugar levels. This inhibition leads to a decrease in blood sugar levels, which can help to manage diabetes. Further research is needed to fully understand the mechanism of action of Apetiviton BC.","oneSentence":"Apetiviton BC is a drug that works by inhibiting the action of a specific enzyme.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:42:55.287Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Type 2 diabetes"}]},"trialDetails":[{"nctId":"NCT01086865","phase":"PHASE3","title":"Clinical Study Phase III, Randomized, Double-blind, Prospective and Comparative to Evaluate the Efficacy and Tolerability of Using APETIVITON BC Compared to Petivit BC in Appetite Stimulate.","status":"UNKNOWN","sponsor":"Cifarma Cientifica Farmaceutica Ltda","startDate":"2010-08","conditions":"Inappetence","enrollment":150}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":59195,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Petivit Bc"],"phase":"phase_3","status":"active","brandName":"Apetiviton BC","genericName":"Apetiviton BC","companyName":"Cifarma Cientifica Farmaceutica Ltda","companyId":"cifarma-cientifica-farmaceutica-ltda","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Apetiviton BC is a small molecule used in clinical trials to evaluate its efficacy and tolerability in stimulating appetite. It has been studied in a Phase III clinical trial for the treatment of inappetence.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}